NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Nautilus Biotechnology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$2.63+0.57 (+27.67%)
Close on Oct 19, 2026
- Market cap
- $334.37M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$1.66 (+171.1%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $334.37M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 2.55
- Dividend yield
- –
- Free cash flow yield
- -15.51%
Fundamentals
- Net income
- -$56.52M
- EPS, diluted
- -$0.45
- Free cash flow
- -$51.86M
- Book value per share
- $1.03
- Diluted shares
- 127M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Net income
-$56.52M
EPS, diluted
-$0.45
Free cash flow
-$51.86M
Reported periodTrailing twelve months